Donald Houston, MD, PhD, FRCPC

Research summary

Dr. Donald Houston's training involved using next-generation sequencing technology to identify structural abnormalities or mutations in the DNA of cancer cells and to understand their impact on cancer cell growth through high-throughput functional screens. He has applied these advanced technologies to a range of malignancies, including breast cancer, lung cancer, and sarcoma. His clinical interests cover a broad spectrum of general hematology, including anemias, hemoglobinopathies, bleeding disorders, thrombosis, myelodysplasias, and myeloproliferative disorders. His active research primarily focuses on bleeding disorders and anemias.

Research interests

• Bleeding disorders
• Coagulation testing
• Iron loading and anemia of chronic disease
• Thrombosis

Research affiliations

• CancerCare Manitoba Research Institute
• Site director, Health Sciences Centre, Hematology Residency Training Program